Suppr超能文献

糖蛋白 mucin-1 负调控胰腺癌中 GalNAc 转移酶 5 的表达。

The glycoprotein mucin-1 negatively regulates GalNAc transferase 5 expression in pancreatic cancer.

机构信息

Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.

Stowers Institute for Medical Research, Kansas City, MO, USA.

出版信息

FEBS Lett. 2019 Oct;593(19):2751-2761. doi: 10.1002/1873-3468.13532. Epub 2019 Jul 21.

Abstract

Aberrant expression of the glycoprotein mucin-1 (MUC1) has been associated with pancreatic cancer progression and metastasis as a result of mediating the oncogenic transcriptional regulation of target genes. In the present study, we demonstrate that MUC1 downregulates the expression of the tumor suppressor polypeptide N-acetylgalactosaminyltransferase 5 in pancreatic cancer. ChIP-on-chip analysis revealed that the MUC1 cytoplasmic tail binds to regulatory elements in the GALNT5 gene. Additionally, MUC1 increases binding of p53 and c-Jun and decreases the binding of Sp1 to the proximal promoter and exonic regions of GALNT5. We also observed that expression of N-acetylgalactosaminyltransferase 5 is inversionally proportional to MUC1 expression in human pancreatic cancer. These results demonstrate that MUC1 downregulates the expression of N-acetylgalactosaminyltransferase 5 in pancreatic cancer by modifying the promoter occupancy of transcription factors through its cytoplasmic domain.

摘要

糖蛋白黏蛋白-1(MUC1)的异常表达与胰腺癌的进展和转移有关,这是由于其介导了靶基因的致癌转录调控。在本研究中,我们证明 MUC1 下调了胰腺癌中肿瘤抑制多肽 N-乙酰半乳糖胺转移酶 5 的表达。ChIP-on-chip 分析显示,MUC1 胞质尾与 GALNT5 基因的调控元件结合。此外,MUC1 增加了 p53 和 c-Jun 的结合,减少了 Sp1 与 GALNT5 近端启动子和外显子区域的结合。我们还观察到,在人胰腺癌中,N-乙酰半乳糖胺转移酶 5 的表达与 MUC1 的表达呈反比关系。这些结果表明,MUC1 通过其胞质结构域改变转录因子的启动子占有率,从而下调胰腺癌中 N-乙酰半乳糖胺转移酶 5 的表达。

相似文献

引用本文的文献

5
The multifaceted role of MUC1 in tumor therapy resistance.MUC1 在肿瘤治疗耐药中的多效性作用。
Clin Exp Med. 2023 Sep;23(5):1441-1474. doi: 10.1007/s10238-022-00978-y. Epub 2022 Dec 23.
10
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.癌症中的糖基化改变:生物标志物和治疗的有希望的靶点。
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188464. doi: 10.1016/j.bbcan.2020.188464. Epub 2020 Nov 4.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验